§ Comparison

Retatrutide vs Tirzepatide

Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.

Retatrutide
14
vendors tracked
from $2.90/mg
Tirzepatide
10
vendors tracked
from $2.08/mg
◎ Cheapest $/mg:Tirzepatide at $2.08/mg

Retatrutide

Triple GCG/GIP/GLP-1 agonist

Operational
$29.00
$2.90/mg
In stockOn sale
Buy with code →
Operational
$54.50
$5.45/mg
In stock87.9% vs best
Visit →
Operational
$78.00
$7.80/mg
Out of stock169.0% vs best
Visit →
Operational
$79.00
$7.90/mg
In stock172.4% vs best
Visit →
$103.99
$10.40/mg
In stock258.6% vs best
Visit →
Operational
$107.25
$10.72/mg
In stock269.8% vs best
Visit →
Operational
$109.00
$10.90/mg
In stock275.9% vs best
Visit →
$109.00
$10.90/mg
In stock275.9% vs best
Visit →
Operational
$109.99
$11.00/mg
Out of stock279.3% vs best
Visit →
$129.99
$13.00/mg
Out of stock348.2% vs best
Visit →
$188.99
$18.90/mg
In stock551.7% vs best
Visit →
Sort:
2026-05-04

Tirzepatide

Dual GLP-1/GIP agonist

Operational
$24.00
$2.40/mg
In stock◎ Best $/mg
Buy with code →
Operational
$89.99
$9.00/mg
In stock275.0% vs best
Visit →
Operational
$99.00
$9.90/mg
In stock312.5% vs best
Visit →
$99.99
$10.00/mg
In stock316.6% vs best
Visit →
$286.20
$28.62/mg
In stockOn sale1092.5% vs best
Visit →
Sort:
2026-05-04

About Retatrutide

An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.

About Tirzepatide

A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.